Comparison of Conservative Treatment Options in the Management of Erectile Dysfunction
Primary Purpose
Erectile Dysfunction
Status
Recruiting
Phase
Not Applicable
Locations
Brazil
Study Type
Interventional
Intervention
LISWT Group
NARFT Group
Sham Group
Sponsored by
About this trial
This is an interventional treatment trial for Erectile Dysfunction focused on measuring Extracorporeal Shockwave Therapy, Radiofrequency Therapy
Eligibility Criteria
Inclusion Criteria:
- 30-80 years.
- Men with a report of complaints of erectile dysfunction.
Exclusion Criteria:
- History of neurological disease.
- History of diabetes mellitus.
- History of Peyronie's disease.
- History of psychiatric illness.
- History of prostatectomy.
- Patients with anatomical malformations in the genital region.
- Penile prosthesis users.
Sites / Locations
- Centro de Atenção ao Assoalho PelvicoRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Experimental
Sham Comparator
Arm Label
LISWT Group
NARFT Group
Sham Group
Arm Description
Participants who will submitted to active procedure with Low Intensuty Shockwave Therapy.
Participants who will submitted to active procedure with Non-Ablative Radiofrequency Therapy
Participants who submitted to sham procedure with vaccum therapy.
Outcomes
Primary Outcome Measures
Change in peak systolic velocity
Performed by means of ultrasonography with doppler of the penis through the induction of the erection, being considered arterial insufficiency the value below 25 cm / s
Change in end diastolic velocity
Performed by means of ultrasonography with doppler of the penis through the induction of the erection, being considered venous occlusive disease the value above 5 cm / s
Change in cavernous artery diameter
Performed by means of ultrasonography with doppler of the penis through the induction of the erection.
Secondary Outcome Measures
Change in International Index of Erectile Function
It is a questionnaire with 5 questions about penile erection that can vary from 5 to 25 points. Higher scores indicate better clinical condition.
Change in Questionnaire of Erectile Quality
It is a questionnaire with 6 questions about the quality of erection based on the Likert scale. That is, it does not offer number values.
Change in measurement of penis length and diameter.
These measurements are made with a paper ruler with the penis flaccid and after ten minutes of induction for erection.
Full Information
NCT ID
NCT04885101
First Posted
November 24, 2020
Last Updated
June 21, 2023
Sponsor
Centro de Atenção ao Assoalho Pélvico
Collaborators
Indústria Brasileira Equipamentos Médicos - IBRAMED
1. Study Identification
Unique Protocol Identification Number
NCT04885101
Brief Title
Comparison of Conservative Treatment Options in the Management of Erectile Dysfunction
Official Title
Comparison of Conservative Treatment Options in the Management of Erectile Dysfunction: Randomized Controlled Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 1, 2021 (Actual)
Primary Completion Date
July 2023 (Anticipated)
Study Completion Date
July 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centro de Atenção ao Assoalho Pélvico
Collaborators
Indústria Brasileira Equipamentos Médicos - IBRAMED
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
This is a randomized clinical trial study with the formation of three groups. After signing the informed consent form, in two copies of equal content, the patient will be evaluated by an experienced physiotherapist and will answer a questionnaire of socio-demographic data and basic anamnesis.
Then, in a private and individualized room, participants will be guided by researchers trained to complete the self-administered questionnaires: International Erectile Function Index (IIFE), Erection Quality Questionnaire (EQQ), SF-36 and Hospital Anxiety Scale and Depression (EHAD). After applying the questionnaires, a physical evaluation by an experienced physiotherapist will be performed.
To induce erection of the penis an injection of a vasoactive agent (prostaglandin E1, alprostadil) will be administered in the corpora cavernosa. Then the length of the penis (swollen, elongated and flaccid) and penile circumference will be measured. Soon after, Dynamic Doppler Ultrasonography with Penis Doppler (UDDP) will be performed. The parameters that will be used in the UDDP to provide a general vascular diagnosis include Peak Systolic Speed (VSP), Final Diastolic Speed (VDF) and Resistive Index (IR).
In the case of a controlled and randomized clinical trial, the patient may be randomly allocated to one of three groups: the Non-Ablative Radiofrequency group (NARFT); the Low Intensity Shockwave Therapy Group (LISWT) and; the Sham Group that will perform the Vacuum Therapy (SHAM). In the NARFT group, the radio frequency will be applied, the device used will be the HERTIX Radiofrequency. The shock wave therapy application protocol in the LISWT group will use the THORK Shock Wave. While in the SHAM group, the vacuum therapy will be used, the research subjects will use the automatic version with simple on / off and release valve commands.
As in the other groups, participants in the Sham group will have a session every seven days for eight weeks. The entire evaluation protocol will be applied before (pre-test) and after treatment (post-test).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Erectile Dysfunction
Keywords
Extracorporeal Shockwave Therapy, Radiofrequency Therapy
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The study will be conducted men diagnosed with Erectile Dysfunction alocated in three groups: Non-Ablative Radiofrequency Therapy (NARFT), Low Intensity Shockwave Therapy (LISWT) or Sham.
Masking
Investigator
Masking Description
The investigator won't be aware where participants will be allocated.
Allocation
Randomized
Enrollment
60 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
LISWT Group
Arm Type
Experimental
Arm Description
Participants who will submitted to active procedure with Low Intensuty Shockwave Therapy.
Arm Title
NARFT Group
Arm Type
Experimental
Arm Description
Participants who will submitted to active procedure with Non-Ablative Radiofrequency Therapy
Arm Title
Sham Group
Arm Type
Sham Comparator
Arm Description
Participants who submitted to sham procedure with vaccum therapy.
Intervention Type
Procedure
Intervention Name(s)
LISWT Group
Intervention Description
The treatment consists of a weekly session and 4,000 pulses will be emitted each of the eight sessions totaling 32,000 pulses with a frequency of 18Hz and 100mJ of energy.
Intervention Type
Procedure
Intervention Name(s)
NARFT Group
Intervention Description
The device used will be with an intensity of 350 Wpp; 75% pulsed operation mode; frequency of 640 kHz, 1200 kHz and 2400 kHz. Eight radio frequency sessions will be held with an interval of seven days between them.
Intervention Type
Procedure
Intervention Name(s)
Sham Group
Intervention Description
In the RNA group, radiofrequency will be applied, the device used will be the Nèartek Esthetic Ibramed - Tecarterapia e Radiofrequency Apparatus, with an intensity of 350 Wpp; 75% pulsed operation mode; frequency of 640 kHz, 1200 kHz and 2400 kHz. The radiofrequency will be applied with the patient in the supine position on both sides of the penis with an opposite dispersion plate against the radiofrequency emitter. To perform the procedure, the therapist will use a glove. Eight radio frequency sessions will be held with an interval of seven days between them.
Primary Outcome Measure Information:
Title
Change in peak systolic velocity
Description
Performed by means of ultrasonography with doppler of the penis through the induction of the erection, being considered arterial insufficiency the value below 25 cm / s
Time Frame
Change from baseline peak systolic velocity immediately after intervention.
Title
Change in end diastolic velocity
Description
Performed by means of ultrasonography with doppler of the penis through the induction of the erection, being considered venous occlusive disease the value above 5 cm / s
Time Frame
Change from baseline end diastolic velocity immediately after intervention.
Title
Change in cavernous artery diameter
Description
Performed by means of ultrasonography with doppler of the penis through the induction of the erection.
Time Frame
Change from baseline cavernous artery diameter immediately after intervention.
Secondary Outcome Measure Information:
Title
Change in International Index of Erectile Function
Description
It is a questionnaire with 5 questions about penile erection that can vary from 5 to 25 points. Higher scores indicate better clinical condition.
Time Frame
Change from baseline International Index of Erectile Function immediately after intervention.
Title
Change in Questionnaire of Erectile Quality
Description
It is a questionnaire with 6 questions about the quality of erection based on the Likert scale. That is, it does not offer number values.
Time Frame
Change from baseline Questionannaire of Erectile Quality immediately after intervention.
Title
Change in measurement of penis length and diameter.
Description
These measurements are made with a paper ruler with the penis flaccid and after ten minutes of induction for erection.
Time Frame
Change from baseline measurement of penis lenght and diameter immediately after intervention.
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
30-80 years.
Men with a report of complaints of erectile dysfunction.
Exclusion Criteria:
History of neurological disease.
History of diabetes mellitus.
History of Peyronie's disease.
History of psychiatric illness.
History of prostatectomy.
Patients with anatomical malformations in the genital region.
Penile prosthesis users.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Patrícia V Lordêlo, PhD
Phone
+5571988592400
Email
pvslordelo@hotmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Carlos S Mamede, MD
Phone
+5571988683967
Email
carlosandrejpa@gmail.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patrícia V Lordêlo, PhD
Organizational Affiliation
Centro de Atenção Pélvica - CAAP
Official's Role
Study Chair
Facility Information:
Facility Name
Centro de Atenção ao Assoalho Pelvico
City
Salvador
State/Province
Ba
ZIP/Postal Code
40.290-000
Country
Brazil
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Patricia V Lordelo, Phd
Phone
+5571988592400
Email
pvslordelo@hotmail.com
12. IPD Sharing Statement
Citations:
PubMed Identifier
8510302
Citation
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA. 1993 Jul 7;270(1):83-90. No abstract available.
Results Reference
background
PubMed Identifier
16422984
Citation
McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, Xin ZC. Disorders of orgasm and ejaculation in men. J Sex Med. 2004 Jul;1(1):58-65. doi: 10.1111/j.1743-6109.2004.10109.x.
Results Reference
background
PubMed Identifier
28751439
Citation
Mobley DF, Khera M, Baum N. Recent advances in the treatment of erectile dysfunction. Postgrad Med J. 2017 Nov;93(1105):679-685. doi: 10.1136/postgradmedj-2016-134073. Epub 2017 Jul 27.
Results Reference
background
PubMed Identifier
8254833
Citation
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994 Jan;151(1):54-61. doi: 10.1016/s0022-5347(17)34871-1.
Results Reference
background
PubMed Identifier
16985979
Citation
Stein RA. Endothelial dysfunction, erectile dysfunction, and coronary heart disease: the pathophysiologic and clinical linkage. Rev Urol. 2003;5 Suppl 7(Suppl 7):S21-7.
Results Reference
background
PubMed Identifier
10731462
Citation
Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB. Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med. 2000 Apr;30(4):328-38. doi: 10.1006/pmed.2000.0643.
Results Reference
background
PubMed Identifier
26839519
Citation
Mobley D, Baum N. Smoking: Its Impact on Urologic Health. Rev Urol. 2015;17(4):220-5.
Results Reference
background
PubMed Identifier
16530932
Citation
Wespes E, Amar E, Hatzichristou D, Hatzimouratidis K, Montorsi F, Pryor J, Vardi Y; EAU. EAU Guidelines on erectile dysfunction: an update. Eur Urol. 2006 May;49(5):806-15. doi: 10.1016/j.eururo.2006.01.028. Epub 2006 Feb 9.
Results Reference
background
PubMed Identifier
23343170
Citation
Porst H, Burnett A, Brock G, Ghanem H, Giuliano F, Glina S, Hellstrom W, Martin-Morales A, Salonia A, Sharlip I; ISSM Standards Committee for Sexual Medicine. SOP conservative (medical and mechanical) treatment of erectile dysfunction. J Sex Med. 2013 Jan;10(1):130-71. doi: 10.1111/jsm.12023.
Results Reference
background
PubMed Identifier
6108446
Citation
Chaussy C, Brendel W, Schmiedt E. Extracorporeally induced destruction of kidney stones by shock waves. Lancet. 1980 Dec 13;2(8207):1265-8. doi: 10.1016/s0140-6736(80)92335-1.
Results Reference
background
PubMed Identifier
29119841
Citation
Chung E, Wang J. A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction. Expert Rev Med Devices. 2017 Dec;14(12):929-934. doi: 10.1080/17434440.2017.1403897. Epub 2017 Nov 29.
Results Reference
background
Learn more about this trial
Comparison of Conservative Treatment Options in the Management of Erectile Dysfunction
We'll reach out to this number within 24 hrs